SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
S*Bio to Initiate Global Phase 3 Clinical Trials of its Novel JAK2 Inhibitor Pacritinib for Treatment of Myelofibrosis (MF)